Deutsche Bank Starts Clover Health (CLOV) at Buy
Tweet
Share
E-mail
Get Alerts CLOV Hot Sheet
Price: $4.71 +8.53%
Rating Summary:
3 Buy, 4 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 14 | New: 59
Rating Summary:
3 Buy, 4 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 14 | New: 59
Join SI Premium – FREE
Deutsche Bank analyst George Hill initiates coverage on Clover Health (NASDAQ: CLOV) with a Buy rating and a price target of $6.00.
For an analyst ratings summary and ratings history on Clover Health click here. For more ratings news on Clover Health click here.
Shares of Clover Health closed at $4.34 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Microsoft plans data center push to triple its computing power - Bloomberg
- TTM Technologies prices $500M in senior notes due 2034
- ARC Group to acquire Malaysia's Firstborn Top Capital in $1.09B deal
Create E-mail Alert Related Categories
New CoverageRelated Entities
Deutsche Bank, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
